On the way from SARS-CoV-sensitive mice to murine COVID-19 model
The coronavirus disease 2019 (COVID-19) is a master killer which appeared suddenly and which has already claimed more than 200,000 human lives. In this situation, laboratories are in urgent need for a COVID-19 murine model to search for effective antiviral compounds. Here we propose...
Main Authors: | Vladislav O. Soldatov, Marina V. Kubekina, Yulia Yu. Silaeva, Alexandra V. Bruter, Alexey V. Deykin |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2020-05-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.pensoft.net/article/53633/download/pdf/ |
Similar Items
-
Using CRISPR/Cas9 for generation the cd209 knockout is a way to get cattle breeds resistant to the Bovine leukemia virus (BLV)
by: Deykin Alexey V., et al.
Published: (2020-01-01) -
Gene editing CRISPR/Cas9 system for producing cows with hypoallergenic milk on the background of a beta-lactoglobulin gene knockout
by: Silaeva Yulia Yu., et al.
Published: (2020-01-01) -
Transgenic mice Cre-dependently expressing mutant polymerase-gamma: novel test-system for pharmacological study of mitoprotective drugs
by: Marina V. Kubekina, et al.
Published: (2021-09-01) -
New personalized genetic mouse model of Lesch-Nyhan syndrome for pharmacology and gene therapy
by: Vladislav Kalmykov, et al.
Published: (2018-12-01) -
Production of hornless dairy cattle from genome-edited blastocysts
by: Deykin Alexey V., et al.
Published: (2020-01-01)